Article
ANO5-muscular dystrophy: clinical, pathological and molecular findings.
European journal of neurology - 1 Oct 2013
Liewluck T, Winder T L, Dimberg E L, Crum B A, Heppelmann C J, Wang Y, Bergen H R, Milone M
Abstract excerpt
BACKGROUND AND PURPOSE: Anoctamin 5 (ANO5) is a putative intracellular calcium-activated chloride channel. Recessive mutations in ANO5 cause primary skeletal muscle disorders (limb-girdle muscular dystrophy 2L and distal muscular dystrophy), which are phenotypically similar to dysferlinopathy, a muscular dystrophy due to dysferlin-encoding gene (DYSF) mutations. METHODS: This study reports the phenotype and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
